Catalent PT receives Investment Bank Analyst Rating Update
- ByInvesting.com-
By Daniel Shvartsman Investing.com -- Entering the last trading day of the year, it's no surprise to find the 2022 scoreboard filled with energy winners and tech losers. The Dow...
By Manas Mishra and Michael Erman (Reuters) -Moderna Inc on Thursday cut its 2022 COVID-19 vaccine sales forecast, citing regulatory and production delays, and issued a 2023...
Last week’s stock market rally had a few anomalies that investors should cast a wary eye on. The main oddity saw investors pull billions of dollars out of two of the biggest...
Last August, a little section of U.S. President Joe Biden’s much-touted Inflation Reduction Act caught the attention of investors. It introduced a 1% tax on stock...
The COVID-19 pandemic highlighted the importance of health care and the role biopharma companies play in drug and vaccine development. As a result, the sector grew tremendously...
Catalent, Inc. is a provider of development and manufacturing solutions for drug, cell and gene therapies biologics, vaccines, and consumer health products. The Company’s segments include Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. Its Biologics segment provides development and manufacturing for protein, plasmid DNA mRNA, cell therapy, viral vaccines and viral-based gene therapies. Its Softgel and Oral Technologies segment provide formulation, development, and manufacturing services for soft capsules, as well as large-scale manufacturing of oral solid dose forms. Its Oral and Specialty Delivery segment provides formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. Its Clinical Supply Services segment provides manufacturing, packaging, storage, distribution, and inventory management for, drugs, biologics and clinical trials.
| Average | 69.33 (+22.41% Upside) |
| High | 100.00 |
| Low | 44.00 |
| Price | 56.64 |
| No. of Analysts | 12 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Buy | Buy | Buy | Sell |
| Technical Indicators | Buy | Strong Sell | Strong Buy | Strong Buy | Strong Sell |
| Summary | Neutral | Neutral | Strong Buy | Strong Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 88.31 | 88.94 | 83.20 | +3.67 | +4.34% | 96.89M | NASDAQ | |||
| 108.80 | 108.82 | 106.54 | +7.37 | +7.27% | 43.60M | NASDAQ | |||
| 28.39 | 29.03 | 27.64 | +1.04 | +3.80% | 7.57M | NASDAQ | |||
| 175.99 | 178.63 | 175.09 | +0.46 | +0.26% | 2.44M | NASDAQ | |||
| 188.27 | 196.75 | 182.61 | +6.86 | +3.78% | 214.41M | NASDAQ | |||
| 470.83 | 495.00 | 463.89 | -26.17 | -5.27% | 11.13M | NYSE | |||
| 2.77 | 2.985 | 2.71 | +0.190 | +7.36% | 3.40M | NYSE | |||
| 103.51 | 104.78 | 102.82 | -1.88 | -1.78% | 4.35M | NYSE | |||
| 112.25 | 112.37 | 110.89 | +0.43 | +0.38% | 5.00M | NYSE | |||
| 169.97 | 170.56 | 168.51 | -1.59 | -0.93% | 5.59M | NASDAQ | |||
| 41.11 | 41.15 | 39.73 | +1.14 | +2.85% | 21.29M | NASDAQ | |||
| 0.45 | 0.48 | 0.41 | +0.07 | +16.90% | 3.76M | NASDAQ | |||
| 188.77 | 197.16 | 180.16 | +35.65 | +23.28% | 149.57M | NASDAQ | |||
| 83.94 | 84.03 | 81.90 | +1.62 | +1.97% | 8.21M | NYSE | |||
| 112.91 | 114.00 | 108.88 | +7.76 | +7.38% | 142.72M | NASDAQ |